-+ 0.00%
-+ 0.00%
-+ 0.00%

SOUFFLÉ THERAPEUTICS™ ANNOUNCES OVERSUBSCRIBED $135 MILLION SERIES B FINANCING TO ADVANCE LEAD CLINICAL PROGRAMS AND CONTINUED PIPELINE PROGRESS

Reuters·10/13/2026 14:00:05

Please log in to view news